Home › Funds › BOUSSARD & GAVAUDAN GESTION SAS › ANIP
BOUSSARD & GAVAUDAN GESTION SAS position in ANIP
ANI PHARMACEUTICALS INC · Health Care
BOUSSARD & GAVAUDAN GESTION SAS reported holding 5,800 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.81% of its reported portfolio and ranking #31 among its reported holdings. BOUSSARD & GAVAUDAN GESTION SAS has disclosed ANIP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How BOUSSARD & GAVAUDAN GESTION SAS's ANIP position evolved
BOUSSARD & GAVAUDAN GESTION SAS first disclosed a stake in ANIP in Q2 2026 at 13,000 shares (US$17.1M). Across 2 filings, BOUSSARD & GAVAUDAN GESTION SAS increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,800 shares valued at US$6.8M — a reduction of -7,200 shares quarter over quarter.. Notable position changes include a 55% trim in Q3 2026 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 13.00K | $17.07M | New |
| Q3 2026 | 5.80K | $6.83M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIP and 13F data
ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIP
- Soleus Capital Management, L.P. 867.76K sh · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K sh · $58.57M · Q2 2026
- Global Alpha Capital Management Ltd. 558.00K sh · $46.19M · Q2 2026
- Empyrean Capital Partners, LP 23.00M sh · $29.75M · Q2 2026
- Ranger Investment Management, L.P. 343.15K sh · $28.41M · Q2 2026
- HBK INVESTMENTS L P 20.15M sh · $26.12M · Q2 2026
- Ikarian Capital, LLC 272.08K sh · $22.52M · Q2 2026
- Jones Hill Capital LP 233.81K sh · $19.35M · Q2 2026
- Penn Capital Management Company, LLC 207.36K sh · $17.18M · Q2 2026
- Parkman Healthcare Partners LLC 202.91K sh · $16.80M · Q2 2026
- Boussard & Gavaudan Investment Management LLP 13.35K sh · $16.46M · Q1 2026
- ABSOLUTE INVESTMENT ADVISERS, LLC 11.72M sh · $15.17M · Q2 2026
More on BOUSSARD & GAVAUDAN GESTION SAS
FAQ
How long has BOUSSARD & GAVAUDAN GESTION SAS held ANIP?
BOUSSARD & GAVAUDAN GESTION SAS has disclosed ANIP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is BOUSSARD & GAVAUDAN GESTION SAS's current position in ANIP?
As of Q3 2026, BOUSSARD & GAVAUDAN GESTION SAS holds 5.80K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $6.83M, representing 0.81% of its reported portfolio and ranking #31.
Has BOUSSARD & GAVAUDAN GESTION SAS been buying or selling ANIP?
In the latest 13F filing (Q3 2026), BOUSSARD & GAVAUDAN GESTION SAS reduced its position in ANIP.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.